Johnson & Johnson
JNJ
#19
Rank
NZ$991.97 B
Marketcap
NZ$411.63
Share price
-0.30%
Change (1 day)
44.03%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): NZ$19.20

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$18.87. an increase over its 2024 EPS that were of NZ$11.34.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025NZ$18.7265.13%
2024NZ$11.34-53.6%
2023NZ$24.43111.16%
2022NZ$11.57-13.84%
2021NZ$13.4341.81%
2020NZ$9.47-18.92%
2019NZ$11.6821.2%
2018NZ$9.641125.3%
2017NZ$0.79-92.23%
2016NZ$10.127.37%
2015NZ$9.42-4.16%
2014NZ$9.8318.1%
2013NZ$8.3224.88%
2012NZ$6.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.47-33.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.30-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.35-66.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.28-66.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$39.00 106.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.50-81.46%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$11.04-41.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$14.38-23.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.38-34.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.38-66.17%๐Ÿ‡ฌ๐Ÿ‡ง UK